Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innohep Weight-Adjusted Dosing in Pregnancy
NCT00851864Phase 4Completed
- Sponsor
- University of Calgary
- Start
- Oct 2007
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tinzaparin in venous thromboembolism (VTE), sponsored by University of Calgary. Started Oct 2007; status: completed.
02
Drugs
tinzaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00851864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851864.